Related Experiment Video
Updated: May 19, 2026
08:31
Bioprinting of Hydrogel Tumor Slices as a 3D Model for Mantle Cell Lymphoma
Published on: September 12, 2025
[The research progress on Langerhans cell tumor - review]
Jia Zhang1, Yi-Ni Wang, Zhao Wang
1Department of Hematology, Capital Medical University, Beijing, China.
Zhongguo Shi Yan Xue Ye Xue Za Zhi
|August 31, 2012
Summary
Langerhans cell tumors include benign Langerhans cell histiocytosis (LCH) and aggressive Langerhans cell sarcoma (LCS). Diagnosis relies on pathology, with varied treatments and prognoses based on disease type and extent.
Area of Science:
- Oncology
- Dermatology
- Pathology
Context:
- Langerhans cell tumors originate from Langerhans cells (LC).
- Two main subtypes exist: Langerhans cell histiocytosis (LCH) and Langerhans cell sarcoma (LCS).
- LCH is a benign proliferation, while LCS is a rare, aggressive malignancy.
Purpose:
- To review the pathogenesis, clinical manifestations, diagnosis, treatment, and prognosis of LCH and LCS.
- To differentiate between LCH and LCS based on cytologic and ultrastructural features.
- To highlight the current challenges in optimal treatment strategies for these rare tumors.
Summary:
- Langerhans cell tumors encompass LCH (benign) and LCS (malignant), differing in cytologic features and behavior.
- Diagnosis involves histopathology, immunohistochemistry, and electron microscopy.
- Treatment is individualized, including surgery, chemotherapy, radiotherapy, immunotherapy, and stem cell transplantation, with varied prognoses.
Impact:
- Provides a comprehensive overview of Langerhans cell tumors for researchers and clinicians.
- Emphasizes the need for individualized treatment approaches.
- Contributes to understanding the distinct clinical behaviors and prognoses of LCH and LCS.
Related Concept Videos
02:57Targeted Cancer Therapies
The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against specific...
There are several types of targeted therapies against specific...
02:07Tumor Progression
Tumor progression is a phenomenon where the pre-formed tumor acquires successive mutations to become clinically more aggressive and malignant. In the 1950s, Foulds first described the stepwise progression of cancer cells through successive stages.
Colon cancer is one of the best-documented examples of tumor progression. Early mutation in the APC gene in colon cells causes a small growth on the colon wall called a polyp. With time, this polyp grows into a benign, pre-cancerous tumor. Further...
Colon cancer is one of the best-documented examples of tumor progression. Early mutation in the APC gene in colon cells causes a small growth on the colon wall called a polyp. With time, this polyp grows into a benign, pre-cancerous tumor. Further...